Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 588820
                    [Title] => Roche drug helps women with ovarian cancer live longer
                    [Summary] => 
Roche recently announced results from a Phase III study of bevacizumab that showed women with previously untreated advanced ovarian cancer who received bevacizumab in combination with chemotherapy, followed by the continuation of bevacizumab alone, had a 39 percent improvement in the likelihood of living longer without the disease worsening (progression-free survival or PFS) compared to chemotherapy alone.
                    [DatePublished] => 2010-07-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

DR. ROBERT BURGER

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 588820
                    [Title] => Roche drug helps women with ovarian cancer live longer
                    [Summary] => 
Roche recently announced results from a Phase III study of bevacizumab that showed women with previously untreated advanced ovarian cancer who received bevacizumab in combination with chemotherapy, followed by the continuation of bevacizumab alone, had a 39 percent improvement in the likelihood of living longer without the disease worsening (progression-free survival or PFS) compared to chemotherapy alone.
                    [DatePublished] => 2010-07-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Roche drug helps women with ovarian cancer live longer

July 1, 2010 - 12:00am

Roche recently announced results from a Phase III study of bevacizumab that showed women with previously untreated advanced ovarian cancer who received bevacizumab in combination with chemotherapy, followed by the...

Science and Environment